Publication: 78

Publication: 78

NCCTG phase I trial of Everolimus (RAD001) and Temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients (N057K).

URL

Google Scholar

Citation:: Mol Cancer Ther vol 8 (12s) abstr C56

Meeting Instance:: EORTC-NCI-AACR 2009
Year:: 2009
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 47 2149

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: J. N. Sarkaria E. Galanis P. J. Peller P. D. Brown W. Wu S. J. Felten J. H. Uhm C. Giannini K. A. Jaeckle J. C. Buckner

Networks:

Study: NCCTG-N057K
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1,2

Keywords: